FlaggedRx← Medication recall checkHome
Class II · ModerateActive recall

Amoxicillin and Clavulanate Potassium for Oral Suspension USP

Could cause temporary or reversible harm; serious harm is unlikely.

Does this affect you?
Check your lot numberLot # 100062316, Exp Date: 01/2026
Where it was soldDistributed in three (3) States: MS, OH, CA.
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.

What happened

Subpotent drug; Clavulanate Potassium component

What to do

  1. Check the lot number and expiry on your medicine against the recall above.
  2. Talk to your pharmacist or doctor before changing anything — don't stop on your own.
  3. Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).

Who makes it

Distributed by / forTeva Pharmaceuticals USA, Inc., Parsippany, NJ 07054
NDC0093-2277-7
Show the full FDA record
Full product labelAmoxicillin and Clavulanate Potassium for Oral Suspension USP, 200 mg/28.5 mg per 5mL, 100 mL (when reconstituted), Rx only, manufactured in Canada by: Teva Canada Limited, Toronto, Canada M1B 2K9; Manufactured For: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054 NDC 0093-2277-7.
Recalling firmTeva Pharmaceuticals USA, Inc
DistributionDistributed in three (3) States: MS, OH, CA.
Quantity4680 cartons
Recall initiated2025-10-13
Report date2025-11-12
Recall completed—
Recall numberD-0151-2026
ClassificationClass II
FDA statusOngoing
Origin on fileParsippany NJ United States

Related

Amoxicillin recallsRecent drug recallsCheck another medication

Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗

This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.